207 related articles for article (PubMed ID: 16414053)
1. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases.
Koba S; Hirano T; Ito Y; Tsunoda F; Yokota Y; Ban Y; Iso Y; Suzuki H; Katagiri T
Atherosclerosis; 2006 Nov; 189(1):206-14. PubMed ID: 16414053
[TBL] [Abstract][Full Text] [Related]
2. Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis.
Koba S; Yokota Y; Hirano T; Ito Y; Ban Y; Tsunoda F; Sato T; Shoji M; Suzuki H; Geshi E; Kobayashi Y; Katagiri T
J Atheroscler Thromb; 2008 Oct; 15(5):250-60. PubMed ID: 18981650
[TBL] [Abstract][Full Text] [Related]
3. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
[TBL] [Abstract][Full Text] [Related]
4. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
6. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.
Nishikura T; Koba S; Yokota Y; Hirano T; Tsunoda F; Shoji M; Hamazaki Y; Suzuki H; Itoh Y; Katagiri T; Kobayashi Y
J Atheroscler Thromb; 2014; 21(8):755-67. PubMed ID: 24717762
[TBL] [Abstract][Full Text] [Related]
7. Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
Zhang Q; Ai Y; Dong H; Wang J; Xu L
IUBMB Life; 2019 Feb; 71(2):277-282. PubMed ID: 30414358
[TBL] [Abstract][Full Text] [Related]
8. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
9. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients.
Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Kalboussi N; Ben Rejeb N; Nabli N; Ben Abdelaziz A; Boughazala E; Bouslama A
Metab Syndr Relat Disord; 2010 Dec; 8(6):515-22. PubMed ID: 20715933
[TBL] [Abstract][Full Text] [Related]
11. Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease.
Lin T; Wang L; Guo J; Liu P; Chen L; Wei M; Li G
Angiology; 2018 Sep; 69(8):724-729. PubMed ID: 29310455
[TBL] [Abstract][Full Text] [Related]
12. Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels.
Hayashi T; Koba S; Ito Y; Hirano T
Lipids Health Dis; 2017 Jan; 16(1):21. PubMed ID: 28125987
[TBL] [Abstract][Full Text] [Related]
13. Non-HDL-C is a Better Predictor for the Severity of Coronary Atherosclerosis Compared with LDL-C.
Zhang Y; Wu NQ; Li S; Zhu CG; Guo YL; Qing P; Gao Y; Li XL; Liu G; Dong Q; Li JJ
Heart Lung Circ; 2016 Oct; 25(10):975-81. PubMed ID: 27634241
[TBL] [Abstract][Full Text] [Related]
14. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
[TBL] [Abstract][Full Text] [Related]
15. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease.
Koba S; Hirano T; Kondo T; Shibata M; Suzuki H; Murakami M; Geshi E; Katagiri T
Am Heart J; 2002 Dec; 144(6):1026-35. PubMed ID: 12486427
[TBL] [Abstract][Full Text] [Related]
16. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
17. The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
Dai W; Li Y; Lv YN; Wei CD; Zheng HY
Atherosclerosis; 2014 Apr; 233(2):661-665. PubMed ID: 24561551
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath KV; Cupples LA; White C; Demissie S; Schaefer EJ; Asztalos BF
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):575-9. PubMed ID: 18174456
[TBL] [Abstract][Full Text] [Related]
19. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
20. Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome.
Sekimoto T; Koba S; Mori H; Sakai R; Arai T; Yokota Y; Sato S; Tanaka H; Masaki R; Oishi Y; Ogura K; Arai K; Nomura K; Kosaki R; Sakai K; Tsujita H; Kondo S; Tsukamoto S; Tsunoda F; Shoji M; Matsumoto H; Hamazaki Y; Shinke T
J Atheroscler Thromb; 2021 Nov; 28(11):1161-1174. PubMed ID: 33551393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
